NeurosciencebioRxivPreprint
Therapeutically targeting the classical complement pathway with antisense oligonucleotides in Alzheimer's disease
Yuanyuan Wang, Tiffany Z. Wu, Alvin Gogineni…·Jesse E. Hanson
This study identifies the classical complement pathway as a therapeutic target in Alzheimer's disease and demonstrates the efficacy of antisense oligonucleotides in rescuing synapse loss in mouse models.
4 citations